» Articles » PMID: 14015822

Evidence That the L-asparaginase of Guinea Pig Serum is Responsible for Its Antilymphoma Effects. II. Lymphoma 6C3HED Cells Cultured in a Medium Devoid of L-asparagine Lose Their Susceptibility to the Effects of Guinea Pig Serum in Vivo

Overview
Journal J Exp Med
Date 1963 Jul 1
PMID 14015822
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Cells of the original line of lymphoma 6C3HED, which regularly prove susceptible to the effects of guinea pig serum in vivo, were cultured in Eagle's medium devoid of L-asparagine; after a latent period of 2 or more weeks, during which time the cell population declined markedly, some of the cells began to proliferate, and thereafter continued vigorous growth. On implantation into mice the proliferating cells were found, however, to have completely and permanently lost their susceptibility to the effects of guinea pig serum. By contrast, when cultures of the original line of 6C3HED cells were prepared in Eagle's medium to which L-asparagine was added in a concentration of 20.0 mg/liter or more, they proliferated vigorously from the beginning; after long periods of growth in the enriched medium in vitro they remained susceptible to the effects of guinea pig serum upon test in vivo. Other amino acids, purines, and pyrimidines were unable to substitute for L-asparagine in this relation. Furthermore, a variant subline of 6C3HED cells which had become insensitive to guinea pig serum under in vivo conditions did not require L-asparagine for growth in tissue culture. It seems plain from the findings as a whole, that in 6C3HED cells, L-asparagine dependence in vitro is associated with the in vivo character of guinea pig serum sensitivity, and conversely L-asparagine independent variants are insusceptible to the effects of guinea pig serum. The implications of the findings complement those of a companion paper in which direct evidence is provided that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects.

Citing Articles

Targeting Asparagine Metabolism in Solid Tumors.

Hanada K, Kawada K, Obama K Nutrients. 2025; 17(1.

PMID: 39796613 PMC: 11722615. DOI: 10.3390/nu17010179.


Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting.

Chen C, Xie Y, Qian S Transl Oncol. 2024; 49:102096.

PMID: 39178574 PMC: 11388189. DOI: 10.1016/j.tranon.2024.102096.


Exploring the potential of asparagine restriction in solid cancer treatment: recent discoveries, therapeutic implications, and challenges.

Fontes M, Silva C, Roldan W, Monteiro G Med Oncol. 2024; 41(7):176.

PMID: 38879707 DOI: 10.1007/s12032-024-02424-3.


The integrated stress response in cancer progression: a force for plasticity and resistance.

Lines C, McGrath M, Dorwart T, Conn C Front Oncol. 2023; 13:1206561.

PMID: 37601686 PMC: 10435748. DOI: 10.3389/fonc.2023.1206561.


Possible mechanism of metabolic and drug resistance with L-asparaginase therapy in childhood leukaemia.

Zhou R, Liang T, Li T, Huang J, Chen C Front Oncol. 2023; 13:1070069.

PMID: 36816964 PMC: 9929349. DOI: 10.3389/fonc.2023.1070069.


References
1.
McCoy T, Maxwell M, KRUSE Jr P . The amino acid requirements of the Jensen sarcoma in vitro. Cancer Res. 1959; 19(6, Part 1):591-5. View

2.
Salzman N, Eagle H, SEBRING E . The utilization of glutamine, glutamic acid, and ammonia for the biosynthesis of nucleic acid bases in mammalian cell cultures. J Biol Chem. 1958; 230(2):1001-12. View

3.
Chang R . Differences in inositol requirements of several strains of HeLa, conjunctival and amnion cells. Proc Soc Exp Biol Med. 1958; 99(1):99-102. DOI: 10.3181/00379727-99-24260. View

4.
TALLAN H, Moore S, STEIN W . Studies on the free amino acids and related compounds in the tissues of the cat. J Biol Chem. 1954; 211(2):927-39. View

5.
McCoy T, Maxwell M, KRUSE Jr P . Amino acid requirements of the Novikoff hepatoma in vitro. Proc Soc Exp Biol Med. 1959; 100(1):115-8. DOI: 10.3181/00379727-100-24542. View